249 related articles for article (PubMed ID: 24164584)
1. History of myocardial iron loading is a strong risk factor for diabetes mellitus and hypogonadism in adults with β thalassemia major.
Ang AL; Tzoulis P; Prescott E; Davis BA; Barnard M; Shah FT
Eur J Haematol; 2014 Mar; 92(3):229-36. PubMed ID: 24164584
[TBL] [Abstract][Full Text] [Related]
2. Endocrinopathies, metabolic disorders, and iron overload in major and intermedia thalassemia: serum ferritin as diagnostic and predictive marker associated with liver and cardiac T2* MRI assessment.
Chirico V; Rigoli L; Lacquaniti A; Salpietro V; Piraino B; Amorini M; Salpietro C; Arrigo T
Eur J Haematol; 2015 May; 94(5):404-12. PubMed ID: 25200112
[TBL] [Abstract][Full Text] [Related]
3. Serum ferritin levels and endocrinopathy in medically treated patients with β thalassemia major.
Belhoul KM; Bakir ML; Saned MS; Kadhim AM; Musallam KM; Taher AT
Ann Hematol; 2012 Jul; 91(7):1107-14. PubMed ID: 22281991
[TBL] [Abstract][Full Text] [Related]
4. The impact of genotype on endocrine complications in thalassaemia major.
Skordis N; Michaelidou M; Savva SC; Ioannou Y; Rousounides A; Kleanthous M; Skordos G; Christou S
Eur J Haematol; 2006 Aug; 77(2):150-6. PubMed ID: 16800840
[TBL] [Abstract][Full Text] [Related]
5. [Value of magnetic resonance imaging T2* tests in detecting heart and liver iron overload in patients with β-thalassemia major].
Wu X; Jing Y; Pei F; Chen J; Feng X; He Y; Zhang Y; Li C
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Feb; 33(2):249-52. PubMed ID: 23443782
[TBL] [Abstract][Full Text] [Related]
6. Hypogonadism, diabetes mellitus, hypothyroidism, hypoparathyroidism: incidence and prevalence related to iron overload and chelation therapy in patients with thalassaemia major followed from 1980 to 2007 in the Ferrara Centre.
Gamberini MR; De Sanctis V; Gilli G
Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():158-69. PubMed ID: 19337172
[TBL] [Abstract][Full Text] [Related]
7. Correlative study of iron accumulation in liver, myocardium, and pituitary assessed with MRI in young thalassemic patients.
Christoforidis A; Haritandi A; Tsitouridis I; Tsatra I; Tsantali H; Karyda S; Dimitriadis AS; Athanassiou-Metaxa M
J Pediatr Hematol Oncol; 2006 May; 28(5):311-5. PubMed ID: 16772883
[TBL] [Abstract][Full Text] [Related]
8. Pituitary iron and volume predict hypogonadism in transfusional iron overload.
Noetzli LJ; Panigrahy A; Mittelman SD; Hyderi A; Dongelyan A; Coates TD; Wood JC
Am J Hematol; 2012 Feb; 87(2):167-71. PubMed ID: 22213195
[TBL] [Abstract][Full Text] [Related]
9. Risk factors associated with hypogonadism in β-thalassemia major patients: predictors for a frequent complication of a rare disease.
Albu A; Barbu CG; Antonie L; Vladareanu F; Fica S
Postgrad Med; 2014 Sep; 126(5):121-7. PubMed ID: 25295656
[TBL] [Abstract][Full Text] [Related]
10. Cardiac complications and diabetes in thalassaemia major: a large historical multicentre study.
Pepe A; Meloni A; Rossi G; Caruso V; Cuccia L; Spasiano A; Gerardi C; Zuccarelli A; D'Ascola DG; Grimaldi S; Santodirocco M; Campisi S; Lai ME; Piraino B; Chiodi E; Ascioti C; Gulino L; Positano V; Lombardi M; Gamberini MR
Br J Haematol; 2013 Nov; 163(4):520-7. PubMed ID: 24111905
[TBL] [Abstract][Full Text] [Related]
11. MRI assessment of excess cardiac iron in thalassemia major: When to initiate?
Chen X; Zhang Z; Zhong J; Yang Q; Yu T; Cheng Z; Chan Q; Guo H; Liang B
J Magn Reson Imaging; 2015 Sep; 42(3):737-45. PubMed ID: 26154874
[TBL] [Abstract][Full Text] [Related]
12. Liver iron and serum ferritin levels are misleading for estimating cardiac, pancreatic, splenic and total body iron load in thalassemia patients: factors influencing the heterogenic distribution of excess storage iron in organs as identified by MRI T2*.
Kolnagou A; Natsiopoulos K; Kleanthous M; Ioannou A; Kontoghiorghes GJ
Toxicol Mech Methods; 2013 Jan; 23(1):48-56. PubMed ID: 22943064
[TBL] [Abstract][Full Text] [Related]
13. The relationship between the myocardial T2* value and left ventricular volumetric and functional parameters in thalassemia major patients.
Bayraktaroğlu S; Aydinok Y; Yildiz D; Uluer H; Savaş R; Alper H
Diagn Interv Radiol; 2011 Dec; 17(4):346-51. PubMed ID: 21647857
[TBL] [Abstract][Full Text] [Related]
14. Myocardial and liver iron overload, assessed using T2* magnetic resonance imaging with an excel spreadsheet for post processing in Tunisian thalassemia major patients.
Ouederni M; Ben Khaled M; Mellouli F; Ben Fraj E; Dhouib N; Yakoub IB; Abbes S; Mnif N; Bejaoui M
Ann Hematol; 2017 Jan; 96(1):133-139. PubMed ID: 27730342
[TBL] [Abstract][Full Text] [Related]
15. Combined therapy with desferrioxamine and deferiprone in beta thalassemia major patients with transfusional iron overload.
Daar S; Pathare AV
Ann Hematol; 2006 May; 85(5):315-9. PubMed ID: 16450126
[TBL] [Abstract][Full Text] [Related]
16. Serum ferritin level as a predictor of impaired growth and puberty in thalassemia major patients.
Shalitin S; Carmi D; Weintrob N; Phillip M; Miskin H; Kornreich L; Zilber R; Yaniv I; Tamary H
Eur J Haematol; 2005 Feb; 74(2):93-100. PubMed ID: 15654898
[TBL] [Abstract][Full Text] [Related]
17. Relationship between myocardial T2 values and cardiac volumetric and functional parameters in β-thalassemia patients evaluated by cardiac magnetic resonance in association with serum ferritin levels.
Liguori C; Pitocco F; Di Giampietro I; de Vivo AE; Schena E; Cianciulli P; Zobel BB
Eur J Radiol; 2013 Sep; 82(9):e441-7. PubMed ID: 23639773
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of iron overload complications among patients with b-thalassemia major treated at Dubai Thalassemia Centre.
Belhoul KM; Bakir ML; Kadhim AM; Dewedar HE; Eldin MS; Alkhaja FA
Ann Saudi Med; 2013; 33(1):18-21. PubMed ID: 23458935
[TBL] [Abstract][Full Text] [Related]
19. Correlation of Pancreatic Iron Overload Measured by T2*-Weighted Magnetic Resonance Imaging in Diabetic Patients with β-Thalassemia Major.
Kosaryan M; Rahimi M; Darvishi-Khezri H; Gholizadeh N; Akbarzadeh R; Aliasgharian A
Hemoglobin; 2017 May; 41(3):151-156. PubMed ID: 28762844
[TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease.
Voskaridou E; Douskou M; Terpos E; Papassotiriou I; Stamoulakatou A; Ourailidis A; Loutradi A; Loukopoulos D
Br J Haematol; 2004 Sep; 126(5):736-42. PubMed ID: 15327528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]